TransMedics Group, Inc. (NASDAQ:TMDX) Q3 2020 Earnings Conference Call November 4, 2020 4:30 AM ET Company Participants Brian Johnston – Vice President, Investor Relations- Gilmartin Group Waleed Hassanein – President and Chief Executive Officer Stephen Gordon – Chief Financial Officer Conference Call Participants Cecilia Furlong – Morgan Stanley Allen Gong – J.P. Morgan Suraj Kalia – Oppenheimer & Company Brian Kennedy – Cowen Operator Ladies and gentlemen, thank you for standing by, and welcome to the Tra ...

TransMedics Group, Inc. (NASDAQ:TMDX) Q2 2020 Earnings Conference Call August 5, 2020 4:30 PM ET Company Participants Brian Johnston - Vice President, Investor Relations-Gilmartin Group Waleed Hassanein - President & Chief Executive Officer Stephen Gordon - Chief Financial Officer Conference Call Participants Suraj Kalia - Oppenheimer Josh Jennings - Cowen & Company Operator Good afternoon, everyone. Thank you for standing by and welcome to the TransMedics Q2 2020 Earnings Conference Call. At this time, all ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR TransMedics Group, Inc. (Exact name of registrant as specified in its charter) FORM 10-Q (Mark One) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38891 (Address of principal executive offices) (Zip ...

TransMedics Group, Inc. (NASDAQ:TMDX) Q1 2020 Earnings Conference Call May 6, 2020 4:30 PM ET Company Participants Brian Johnston – Vice President, Investor Relations-Gilmartin Group Waleed Hassanein – President and Chief Executive Officer Stephen Gordon – Chief Financial Officer Conference Call Participants Robbie Marcus – JPMorgan Bryan Bergin – Cowen Suraj Kalia – Oppenheimer Operator Ladies and gentlemen, thank you for standing by, and welcome to the TransMedics Q1 2020 Earnings Conference Call. At this ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38891 TransMedics Group, Inc. (Exact name of registrant as specified in its charter) Massachusetts 83-2181531 ( ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 28, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-38891 TransMedics Group, Inc. (Exact name of Registrant as specified in its Charter) Massachusetts 83-2181531 (State or other jurisd ...

Organ Care System (OCS") Redefining What's Possible in Organ Transplantation | --- | --- | |-------|-------| | | | | | | The OCS is the only technology platform addressing lung, heart and liver transplant therapy Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, including statements about our results of operations, commercial opportunity and the rate of adoption ...

TransMedics Group, Inc. (NASDAQ:TMDX) Q4 2019 Earnings Conference Call March 2, 2020 4:30 PM ET Company Participants Brian Johnston - Managing Director, Gilmartin Group Waleed Hassanein - Founder, President and Chief Executive Officer Stephen Gordon - Chief Financial Officer Conference Call Participants Allen Gong - JPMorgan David Lewis - Morgan Stanley Jason Mills - Canaccord Genuity Group Inc. Operator Good day, ladies and gentlemen, and welcome to the TransMedics Fourth Quarter and Full-Year 2019 Earning ...

Organ Care System (OCS") Redefining What's Possible in Organ Transplantation | --- | --- | |--------------------------------------------------------------------------|-------| | | | | that is transforming organ transplantation to a more dynamic environment | | The OCS is the only technology platform addressing lung, heart and liver transplant therapy Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements. Investors are cautioned not to place undue reliance ...

Transmedics Group, Inc. (NASDAQ:TMDX) Q2 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Gregory Chodaczek - Gilmartin Group Waleed Hassanein - Founder, CEO, President & Director Stephen Gordon - CFO. Treasurer & Secretary Conference Call Participants David Lewis - Morgan Stanley Christian Moore - JPMorgan Chase & Co. Joshua Jennings - Cowen and Company Jason Mills - Canaccord Genuity Corp. Operator Good afternoon, ladies and gentlemen, and welcome to the TransMedics Second Quar ...